Eye ring delivers glaucoma drug for 6 months at a time


Researchers in San Francisco have developed a small ring that rests on the surface of the eye like a contact lens and delivers a glaucoma drug.

The device is a thin silicone ring that can be placed without surgery and delivers the drug bimatoprost over a course of 6 months. The scientists, hailing from the UC Davis Medical Center Glaucoma Service, published the results of their study in the journal Ophthalmology.

In a Phase II test in patients with glaucoma or ocular tension, eye pressure dropped about 20% over 6 months. And despite becoming dislodged in several patients, the device was well-tolerated with a retention rate of 89%.

"In making effective treatments easier for patients, the hope is that we can reduce vision loss from glaucoma, and possibly other diseases," lead author James Brandt said in a statement. "What is exciting is that this is just one of several sustained-release drug delivery methods designed to help patients who have trouble taking daily eye drops."

- here's the release


Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.